TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis

[1]  M. Judson.  The Clinical Features of Sarcoidosis: A Comprehensive Review , 2015, Clinical Reviews in Allergy & Immunology.

[2]  M. Koenders,et al.  The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy. , 2015, Cytokine.

[3]  R. Vandenbroucke,et al.  Is there new hope for therapeutic matrix metalloproteinase inhibition? , 2014, Nature Reviews Drug Discovery.

[4]  Hui Liu,et al.  TNF-like ligand 1A is associated with the pathogenesis of psoriasis vulgaris and contributes to IL-17 production in PBMCs , 2014, Archives of Dermatological Research.

[5]  R. Baughman,et al.  Worsening of pulmonary sarcoidosis , 2014, Current opinion in pulmonary medicine.

[6]  V. Kähäri,et al.  Matrix metalloproteinases in inflammation. , 2014, Biochimica et biophysica acta.

[7]  R. Polverosi,et al.  Typical and atypical pattern of pulmonary sarcoidosis at high-resolution CT: relation to clinical evolution and therapeutic procedures , 2014, La radiologia medica.

[8]  Kori L Wallace,et al.  Immunopathology of inflammatory bowel disease. , 2014, World journal of gastroenterology.

[9]  Minoru Nakamura,et al.  The Role of TL1A and DR3 in Autoimmune and Inflammatory Diseases , 2013, Mediators of inflammation.

[10]  E. Podack,et al.  Immunobiology of TNFSF15 and TNFRSF25 , 2013, Immunologic research.

[11]  L. Jia,et al.  The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation , 2013, Current opinion in gastroenterology.

[12]  W. Drake,et al.  Reversal of Global CD4+ Subset Dysfunction Is Associated with Spontaneous Clinical Resolution of Pulmonary Sarcoidosis , 2013, The Journal of Immunology.

[13]  X. Sun,et al.  Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis , 2013, Scandinavian journal of rheumatology.

[14]  Arianne C. Richard,et al.  TL1A and DR3, a TNF family ligand‐receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation , 2011, Immunological reviews.

[15]  T. Ślebioda,et al.  Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia , 2011, Mucosal Immunology.

[16]  C. Hunter,et al.  Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Fadini,et al.  Sarcoidosis is a Th1/Th17 multisystem disorder , 2010, Thorax.

[18]  T. Hibi,et al.  TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL‐23 in patients with Crohn's disease , 2010, Inflammatory bowel diseases.

[19]  M. Oukka.  Th17 cells in immunity and autoimmunity , 2008, Annals of the rheumatic diseases.

[20]  M. Cassatella,et al.  Pulmonary Sarcoidosis , 2007, Seminars in respiratory and critical care medicine.

[21]  A. Mantovani,et al.  Soluble TNF-Like Cytokine (TL1A) Production by Immune Complexes Stimulated Monocytes in Rheumatoid Arthritis1 , 2007, The Journal of Immunology.

[22]  F. Cominelli,et al.  Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Beghé,et al.  Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.

[24]  B. Kwon,et al.  Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. , 2005, Cytokine.

[25]  修一 野村,et al.  亜鉛不足が原因の味覚障害患者に亜鉛の経口投与で唾液中のTIMP-1 (tissue inhibitor of metalloproteinase-1) , 2003 .

[26]  K. Prikk,et al.  Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF , 2002, European Respiratory Journal.

[27]  Jun Zhang,et al.  TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. , 2002, Immunity.

[28]  J. Bousquet,et al.  Balance in asthma between matrix metalloproteinases and their inhibitors. , 1999, The Journal of allergy and clinical immunology.

[29]  L. Trentin,et al.  Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[30]  M. Chilosi,et al.  Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. , 1998, Journal of immunology.

[31]  N. MacIntyre,et al.  Diffusing capacity of the lung for carbon monoxide. , 1997, Respiratory care clinics of North America.

[32]  R. Zambello,et al.  Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. , 1996, Journal of immunology.

[33]  L. Trentin,et al.  CD8 alveolitis in sarcoidosis: incidence, phenotypic characteristics, and clinical features. , 1993, The American journal of medicine.

[34]  D. Casara,et al.  Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity. , 1989, The Journal of clinical investigation.

[35]  O. Sharma,et al.  Pathogenesis of sarcoidosis. , 1987, The Western journal of medicine.

[36]  W. Shelley.  On the Pathogenesis of Sarcoidosis , 1971, Southern medical journal.

[37]  Y. C. Lee,et al.  Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma. , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.